- Home
- BCBP vs CRVS Comparison
BCBP vs CRVS Comparison
Compare BCBP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CRVS
- Stock Information
- Founded
- BCBP 2000
- CRVS 2014
- Country
- BCBP United States
- CRVS United States
- Employees
- BCBP N/A
- CRVS N/A
- Industry
- BCBP Savings Institutions
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- CRVS Health Care
- Exchange
- BCBP Nasdaq
- CRVS Nasdaq
- Market Cap
- BCBP 143.5M
- CRVS 305.4M
- IPO Year
- BCBP N/A
- CRVS 2016
- Fundamental
- Price
- BCBP $8.94
- CRVS $4.11
- Analyst Decision
- BCBP Hold
- CRVS Strong Buy
- Analyst Count
- BCBP 2
- CRVS 4
- Target Price
- BCBP $11.75
- CRVS $15.00
- AVG Volume (30 Days)
- BCBP 98.2K
- CRVS 1.2M
- Earning Date
- BCBP 07-22-2025
- CRVS 08-05-2025
- Dividend Yield
- BCBP 7.03%
- CRVS N/A
- EPS Growth
- BCBP N/A
- CRVS N/A
- EPS
- BCBP 0.15
- CRVS N/A
- Revenue
- BCBP $63,178,000.00
- CRVS N/A
- Revenue This Year
- BCBP $22.28
- CRVS N/A
- Revenue Next Year
- BCBP $10.55
- CRVS N/A
- P/E Ratio
- BCBP $60.85
- CRVS N/A
- Revenue Growth
- BCBP N/A
- CRVS N/A
- 52 Week Low
- BCBP $7.54
- CRVS $1.78
- 52 Week High
- BCBP $14.04
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- BCBP 68.12
- CRVS 53.94
- Support Level
- BCBP $9.07
- CRVS $3.79
- Resistance Level
- BCBP $9.38
- CRVS $4.31
- Average True Range (ATR)
- BCBP 0.23
- CRVS 0.29
- MACD
- BCBP 0.11
- CRVS 0.00
- Stochastic Oscillator
- BCBP 82.17
- CRVS 72.64
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).